Pathogenesis of multiple sclerosis: an update on immunology.
about
CX3CL1 (fractalkine) and CX3CR1 expression in myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis: kinetics and cellular origin.An extended association screen in multiple sclerosis using 202 microsatellite markers targeting apoptosis-related genes does not reveal new predisposing factorsIL-2 suppression of IL-12p70 by a recombinant HSV-1 expressing IL-2 induces T-cell auto-reactivity and CNS demyelinationSTAT1-induced ASPP2 transcription identifies a link between neuroinflammation, cell polarity, and tumor suppressionEmerging therapies in multiple sclerosis.Neuroprotective effect of transplanted human embryonic stem cell-derived neural precursors in an animal model of multiple sclerosis.Suppression of IL-12p70 formation by IL-2 or following macrophage depletion causes T-cell autoreactivity leading to CNS demyelination in HSV-1-infected mice.MS14, a Marine Herbal Medicine, an Immunosuppressive Drug in Experimental Autoimmune Encephalomyelitis.MS14 down-regulates lipocalin2 expression in spinal cord tissue in an animal model of multiple sclerosis in female C57BL/6.IL-7Rα confers susceptibility to experimental autoimmune encephalomyelitis.Past exposure to sun, skin phenotype, and risk of multiple sclerosis: case-control study.Cannabinoids and neuroinflammation.Epstein-Barr virus latent membrane protein 2A exacerbates experimental autoimmune encephalomyelitis and enhances antigen presentation function.HLA class I & II alleles in multiple sclerosis patients from Puerto Rico.Kappa opioid receptor activation alleviates experimental autoimmune encephalomyelitis and promotes oligodendrocyte-mediated remyelination.Early blood-brain barrier permeability in cerebella of PLSJL mice immunized with myelin basic protein.Fish and egg specific immunoglobin e in multiple sclerosis patients.Role of interleukin-2 and herpes simplex virus 1 in central nervous system demyelination in miceCytokine and chemokine alterations in tissue, CSF, and plasma in early presymptomatic phase of experimental allergic encephalomyelitis (EAE), in a rat model of multiple sclerosis.Down-modulation of programmed death 1 alters regulatory T cells and promotes experimental autoimmune encephalomyelitis.Effect of a Single Bout of Intermittent versus Continuous Walking on Perceptions of Fatigue in People with Multiple Sclerosis.Swift entry of myelin-specific T lymphocytes into the central nervous system in spontaneous autoimmune encephalomyelitis.Cerebrospinal fluid molecular demonstration of Chlamydia pneumoniae DNA is associated to clinical and brain magnetic resonance imaging activity in a subset of patients with relapsing-remitting multiple sclerosis.Human mesenchymal stem cells: from immunophenotyping by flow cytometry to clinical applications.Effects of the PPAR-beta agonist GW501516 in an in vitro model of brain inflammation and antibody-induced demyelination.Human mesenchymal stem cells infiltrate the spinal cord, reduce demyelination, and localize to white matter lesions in experimental autoimmune encephalomyelitis.Therapeutic effect of transplanted human Wharton's jelly stem cell-derived oligodendrocyte progenitor cells (hWJ-MSC-derived OPCs) in an animal model of multiple sclerosis.Induction of experimental allergic encephalomyelitis in a low-susceptible Albino Oxford rat strain by somatostatin analogue SMS 201-995.Experimental Autoimmune Encephalomyelitis Is Successfully Controlled by Epicutaneous Administration of MOG Plus Vitamin D Analog.Win 55212-2, a cannabinoid receptor agonist, attenuates leukocyte/endothelial interactions in an experimental autoimmune encephalomyelitis model.Loss of Gas6 and Axl signaling results in extensive axonal damage, motor deficits, prolonged neuroinflammation, and less remyelination following cuprizone exposure.Disease-modifying treatments modulate myeloid cells in multiple sclerosis patients.Increased frequency of CD4+ CD25+ regulatory T cells in the cerebrospinal fluid but not in the blood of multiple sclerosis patients.Transglutaminase-6 is an autoantigen in progressive multiple sclerosis and is upregulated in reactive astrocytes.Phytosterols ameliorate clinical manifestations and inflammation in experimental autoimmune encephalomyelitis.Increased CD8+ central memory T cells in patients with multiple sclerosis.Methods to assess neuroinflammation.Antineutrophil Cytoplasmic Antibody and Multiple Sclerosis.
P2860
Q24814510-29DC24B8-2366-4834-9E3B-CA13B9F8052AQ24814921-5DA2393E-F3F2-4D6F-9263-1BFD4E1C0DDCQ27437608-181DB2F1-437D-4C13-8299-C0E76304E02FQ30009394-0DEA3053-75B2-47FF-BE24-0F39996192D6Q31015100-E9C65540-74C2-44F1-974C-0CFF51F868B4Q33367115-BAFDC027-A8BF-409D-BDE3-94AF24098299Q33758029-263EFE0B-BC8E-4513-BD0C-A3E5AB1D90D0Q34197306-9F2EDD46-D1C1-4BB7-A627-B437D10CDC4AQ34475822-827D77E6-9EFE-4D92-BB2F-22EB5C75CADAQ34507783-D15B4EE9-9891-4509-8FFC-43234E2373B0Q34536052-F8DA3712-7415-4EEF-9EA1-551F96EEB771Q35046205-48C26825-DBEC-4BA0-94E9-FBACDB71E5A1Q35967534-8FE369D8-5E83-463D-82EF-7C93D9170E30Q36069652-F9387498-C2C6-41FB-B860-CABE2A401638Q36768701-52894D89-FB6D-4605-85DD-1427C1FEE5ACQ36798405-BCD88746-7811-4BDA-8B54-30FFE33CC6C5Q36917709-EEBFA4BC-0C4F-49A6-9BF3-58927FBA9099Q37254368-B4E50568-E18A-492B-8A5B-9D1AC9EC834EQ37417247-0EBA7295-F9CB-4C38-A754-3FDBB76C67B6Q37440145-ACDB115F-DD9E-4A7E-9C29-AE6D4A6AB407Q37442256-C71FD2B4-C0B5-4AB2-8E75-E22D87AE3AD9Q37680135-DE4EE356-F971-45D9-B44F-F49DC5A026C6Q37866587-BAF1470F-6FCA-480E-A796-DC91E5AF70D8Q38048723-AACA8C26-139B-4C1E-977E-1DB13F3952A8Q43121623-E486A09B-A8EF-4497-AC2E-B97541644FC6Q43578851-725943AD-E4FD-4591-A572-88B8BC530C54Q44325852-31AF41B2-9D7E-4B9A-8B0E-FC9080D0A4EEQ46365861-E85ECDE9-0321-44BE-A2F0-B851F04756E6Q46438033-17173348-67FC-4980-B41A-3F055441BD30Q47655490-25542547-1EEF-4D27-9455-89FFCB8FF275Q47963320-90834A95-42AC-4251-8CEE-961E15759052Q48219782-2A7B99B4-506B-4859-873A-232D3FA70407Q48271985-00D9E849-480C-4FBD-90A5-B4F8272CC939Q48273330-5D7C62B2-1055-4F05-BB43-2881F527647EQ51529671-1450A6AC-DFBD-4977-8305-E5F1887D057CQ51976135-041C1B39-015E-44FC-B5ED-762EBF36F0B5Q54340588-B1C70030-0828-4EBD-A433-A59AC6D95FABQ55008912-393D57DF-A660-4748-8F3E-2CE44268A0FC
P2860
Pathogenesis of multiple sclerosis: an update on immunology.
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Pathogenesis of multiple sclerosis: an update on immunology.
@ast
Pathogenesis of multiple sclerosis: an update on immunology.
@en
Pathogenesis of multiple sclerosis: an update on immunology.
@nl
type
label
Pathogenesis of multiple sclerosis: an update on immunology.
@ast
Pathogenesis of multiple sclerosis: an update on immunology.
@en
Pathogenesis of multiple sclerosis: an update on immunology.
@nl
prefLabel
Pathogenesis of multiple sclerosis: an update on immunology.
@ast
Pathogenesis of multiple sclerosis: an update on immunology.
@en
Pathogenesis of multiple sclerosis: an update on immunology.
@nl
P2093
P1476
Pathogenesis of multiple sclerosis: an update on immunology.
@en
P2093
Bernhard Hemmer
Norbert Sommer
Sabine Cepok
Stefan Nessler
P304
P356
10.1097/00019052-200206000-00001
P577
2002-06-01T00:00:00Z